TECVAYLI (teclistamab) demonstrates potential as frontline combination therapy for patients with newly diagnosed multiple myeloma
100 percent of evaluable patients for minimal residual disease (MRD) testing achieved MRD…
Search
Have an existing account?
Sign In
Tag: (teclistamab)